Literature DB >> 18083580

Novel quinazolinone derivatives as 5-HT7 receptor ligands.

Yong Ho Na1, Sung Ho Hong, Jung Hyang Lee, Woo-Kyu Park, Du-Jong Baek, Hun Yeong Koh, Yong Seo Cho, Hyunah Choo, Ae Nim Pae.   

Abstract

5-HT(7) receptor antagonists generated antidepressant-like effects in animal model and the involvement of the 5-HT(7) receptor in other pathophysiological mechanisms such as thermoregulation, learning and memory, and sleep has been highlighted by various studies. As one of our efforts to discover a new type of 5-HT(7) receptor antagonists, we here report on the synthesis and binding affinities to the 5-HT(7) receptor of the quinazolinone library 1, which was designed with various substituents (X, Y, R(1), and R(2)) on the aromatic rings and different carbon chain length. Total 85 compounds of the quinazolinone library 1 were synthesized and the binding affinities of all the synthesized compounds were obtained by radioligand binding assay for the 5-HT(7) receptor. Among the 85 compounds, 24 compounds show very good binding affinities with IC(50) values below 100 nM. Mainly the compounds with IC(50) values below 100 nM have o-OMe or o-OEt as R(2) substituent. The compound with the best binding affinity is 1-68 of which the IC(50) value is 12 nM. In in vivo animal study, some synthesized compounds really have the antidepressant activity in the forced swimming test in mice.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18083580     DOI: 10.1016/j.bmc.2007.11.049

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  6 in total

Review 1.  Serotonin 5-HT7 receptor agents: Structure-activity relationships and potential therapeutic applications in central nervous system disorders.

Authors:  Marcello Leopoldo; Enza Lacivita; Francesco Berardi; Roberto Perrone; Peter B Hedlund
Journal:  Pharmacol Ther       Date:  2010-10-20       Impact factor: 12.310

2.  Antioxidant, anticancer and electrochemical redox properties of new bis(2,3-dihydroquinazolin-4(1H)-one) derivatives.

Authors:  Paramasivam Sivaguru; Kandasamy Parameswaran; Appaswami Lalitha
Journal:  Mol Divers       Date:  2017-05-05       Impact factor: 2.943

3.  Pharmacological blockade of 5-HT7 receptors as a putative fast acting antidepressant strategy.

Authors:  Ouissame Mnie-Filali; Céline Faure; Laura Lambás-Señas; Mostafa El Mansari; Hassina Belblidia; Elise Gondard; Adeline Etiévant; Hélène Scarna; Anne Didier; Anne Berod; Pierre Blier; Nasser Haddjeri
Journal:  Neuropsychopharmacology       Date:  2011-02-16       Impact factor: 7.853

4.  2-(4-Bromo-phen-yl)-2-methyl-2,3-di-hydro-quinazolin-4(1H)-one.

Authors:  Mei-Mei Zhang; Ke Yang; Xiang-Shan Wang
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-04-14

5.  Highly Potent and Selective Dopamine D4 Receptor Antagonists Potentially Useful for the Treatment of Glioblastoma.

Authors:  Pegi Pavletić; Ana Semeano; Hideaki Yano; Alessandro Bonifazi; Gianfabio Giorgioni; Alessandro Piergentili; Wilma Quaglia; Maria Giovanna Sabbieti; Dimitrios Agas; Giorgio Santoni; Roberto Pallini; Lucia Ricci-Vitiani; Emanuela Sabato; Giulio Vistoli; Fabio Del Bello
Journal:  J Med Chem       Date:  2022-09-13       Impact factor: 8.039

6.  Synthesis and anticonvulsant activity of some quinazolin-4-(3H)-one derivatives.

Authors:  Hanan Georgey; Nagwa Abdel-Gawad; Safinaz Abbas
Journal:  Molecules       Date:  2008       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.